Imported-post
-
Optical computing at sub-picosecond speeds developed at Vanderbilt
Vanderbilt researchers have developed the next generation of ultrafast data transmission that may make it possible to make already high-performance computing “on demand.” The technology unjams bottlenecks in data streams using a hybrid silicon-vanadium dioxide waveguide that can turn light on and off in less than one trillionth of a second. The article, “Sub‐Picosecond Response... Read MoreJan 19, 2021
-
Bick selected as first VUMC Discovery Scholar in Health and Medicine
Alexander Bick, MD, PhD, assistant professor of Medicine in the Division of Genetic Medicine at Vanderbilt University Medical Center, has been selected as the first VUMC Discovery Scholar in Health and Medicine. Read MoreJan 14, 2021
-
Mitochondrial stress and hypertension
Oxidative stress and toxic products called isolevuglandins in mitochondria play a role in endothelial dysfunction and hypertension — and getting rid of them with a special “scavenger” molecule has therapeutic potential. Read MoreJan 12, 2021
-
Microbial RNA and rheumatoid arthritis
Small RNAs — short stretches of genetic material — from microbes may be playing a role in rheumatoid arthritis and other autoimmune diseases. Read MoreJan 11, 2021
-
Large study finds higher burden of acute brain dysfunction for COVID-19 ICU patients
COVID-19 patients admitted to intensive care in the early months of the pandemic were subject to a significantly higher burden of delirium and coma than is typically found in patients with acute respiratory failure. Read MoreJan 8, 2021
-
Functional seizures associated with stroke, psychiatric disorders in electronic health records study
In a large-scale study of electronic health records, Vanderbilt University Medical Center investigators have determined the prevalence of functional seizures and characterized comorbidities associated with them. Read MoreJan 7, 2021
-
Vitamin D activation and cancer risk
Vitamin D protection against colon cancer varies according to parathyroid hormone response, particularly among women. Read MoreJan 7, 2021
-
Building a cohort, the easy way
An automated system using keyword searches can help identify candidates for clinical trials on adverse drug reactions. Read MoreJan 7, 2021
-
Genome editing technique “rescues” mice from accelerated aging disorder: study
Researchers from the Broad Institute of Harvard and MIT, the National Institutes of Health (NIH) and Vanderbilt University Medical Center for the first time have used a novel genome-editing technique to “rescue” mice from progeria, a rare genetic disease that causes accelerated aging. Read MoreJan 6, 2021
-
Vanderbilt civil engineer partners with TDOT to seek ways to mitigate opioid epidemic
One of the largest obstacles for patients seeking effective substance abuse treatment is a lack of transportation to the treatment facilities. Vanderbilt University researcher Janey Camp, associate professor of civil and environmental engineering, is working on a project to help clear those roadblocks. Janey Camp (Vanderbilt University) Camp is leading an 18-month, in-depth analysis of... Read MoreJan 6, 2021
-
VUMC, Case Western apply artificial intelligence to “customize” oral cancer treatment
Researchers at Vanderbilt University Medical Center and Case Western Reserve University in Cleveland have been awarded a five-year, $3.3 million grant by the National Cancer Institute to apply artificial intelligence (AI) to help customize treatment for oral cancer patients. Read MoreJan 5, 2021
-
Study reveals distinct genomic landscape for young adults with appendiceal cancer
The first study to compare molecular landscapes of early-onset and late-onset appendiceal cancer has revealed distinct non-silent mutations in the tumors of younger patients, setting the stage for the development of potential therapeutic advances. Read MoreDec 17, 2020
-
Study reveals new strategy for reducing tumor growth, metastasis
A team of Vanderbilt investigators has discovered that blocking a certain signaling pathway boosts antitumor immunity and reduces tumor growth and metastasis in models of breast cancer and melanoma. Read MoreDec 17, 2020
-
COVID-associated delays for elective services studied
This spring in the U.S., there were widespread delays in elective health care procedures and screenings. Read MoreDec 17, 2020
-
A deeper look at out-of-home care
Geographically targeted efforts to prevent children being placed in out-of-home care might be possible, Vanderbilt researchers report. Read MoreDec 15, 2020
-
Computer science team wins global contest with AI model that translates English to code
IBM will use a Vanderbilt model as the end-user scripting assistant in its open-source Command Line AI Project. Read MoreDec 14, 2020
-
Polymer protection for heart muscle
Vanderbilt researchers demonstrate that the polymer P188 has promise as a therapy to prevent reperfusion injury — the cellular damage that occurs when blood flow returns after an ischemic event like a heart attack. Read MoreDec 14, 2020
-
Model students: improving clinical decision-making
Vanderbilt investigators have devised a system to alert health IT teams to deteriorating performance in clinical prediction models. Read MoreDec 10, 2020
-
Exploiting viral vulnerabilities
The isolation of human monoclonal antibodies against dangerous viruses including EEEV, Hendra and Nipah could offer new ways to treat and prevent these infections. Read MoreDec 10, 2020
-
Study sheds light on diabetes and COVID interaction
COVID-19 has been linked to cases of new-onset diabetes, diabetes-related emergencies and a higher death rate among diabetes patients. Read MoreDec 10, 2020